SG Americas Securities, LLC
- SEC CIK
- 0001313360
- Latest filing
- Aug 7, 2026
OTLK holding history
Outlook Therapeutics, Inc. in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OTLK overviewAll 13F holders of OTLKFull Q2 2026 holdings
- Shares (Q2 2026)
- 17,271
- Value
- $27.0K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 17,271 | $27.0K | <0.1% | +17,271 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −1,876−100.0% | Sold outConverted for a 1-for-20 split | Holders |
| Q4 2023 | 37,519 | $15.0K | <0.1% | +17,526+87.7% | Added | Holders |
| Q3 2023 | 19,993 | $4.00K | <0.1% | +19,993 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −61,941−100.0% | Sold out | Holders |
| Q1 2023 | 61,941 | $68.0K | <0.1% | +61,941 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −24,923−100.0% | Sold out | Holders |
| Q3 2022 | 24,923 | $30.0K | <0.1% | +7,221+40.8% | Added | Holders |
| Q2 2022 | 17,702 | $18.0K | <0.1% | +17,702 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −25,235−100.0% | Sold out | Holders |
| Q4 2021 | 25,235 | $34.0K | <0.1% | −19,593−43.7% | Reduced | Holders |
| Q3 2021 | 44,828 | $97.0K | <0.1% | +44,828 | New | Holders |